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Abstract: In a clinical trial, we have previously shown that a telephone intervention can 
signiﬁ  cantly increase participation in dilated fundus examination (DFE) screening among low-
income adults with diabetes. Here the costs and cost-effectiveness ratio of this intervention are 
calculated. Intervention effectiveness was estimated as the difference in DFE utilization between 
the telephone intervention and print groups from the clinical trial multiplied by the size of the 
telephone intervention group. A micro-costing approach was used. Personnel time was aggre-
gated from logs kept during the clinical trial of the intervention. Wage rates were taken from 
a commercial compensation database. Telephone charges were estimated based on prevailing 
fees. The cost-effectiveness ratio was calculated as the ratio of total costs of the intervention 
to the number of DFEs gained by the intervention. A sensitivity analysis estimated the cost-
effectiveness of a more limited telephone intervention. A probabilistic sensitivity analysis using 
bootstrap samples from the clinical trial results quantiﬁ  ed the uncertainties in resource utilization 
and intervention effectiveness. Net intervention costs were US$18,676.06, with an associated 
gain of 43.7 DFEs and 16.4 new diagnoses of diabetic retinopathy. The cost-effectiveness ratio 
is US$427.37 per DFE gained. A restricted intervention limiting the number of calls to 5, as 
opposed to 7, would achieve the same results, but would cost approximately 17% less. In the 
probabilistic sensitivity analysis, the 5th and 95th percentiles of the cost-effectiveness ratio 
were US$304.05 and US$692.52 per DFE gained, respectively. Our telephone intervention is 
more expensive than simple mail or telephone reminders used in other settings to promote pre-
ventive care; it is, however, also considerably more effective, and is effective in a low-income 
minority population at greater risk for diabetes complications. The costs are dominated by labor 
costs, and may be substantially defrayed, without loss of effectiveness, by restricting the number 
of telephone calls to 5 per patient.
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Introduction
The American Diabetes Association recommends that people with diabetes be screened 
regularly with dilated fundus examination (DFE) to detect diabetic retinopathy (DR) 
(Aiello et al 1998; American Diabetes Association 2004). Background and early 
proliferative retinopathy can be readily treated with laser photocoagulation, and such 
treatment reduces the incidence of sight-destroying retinal hemorrhages and other 
severe complications of diabetic retinopathy (Aiello et al 1998).
Notwithstanding the evidence that DFE screening can save sight, and the wide-
spread acceptance of this by physicians, adherence to this recommendation is poor, 
estimated variously at 49% (Brechner et al 1993), 33% (Beckles et al 2007), and 
23% (Taylor et al 2007) in different settings. Even when a physician recommends 
a DFE, typically the patient must then arrange for and keep an appointment for the 
procedure, and sometimes must identify a suitable provider. In addition, patients may Clinical Ophthalmology 2008:2(4) 764
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be unaware of the nature of, need for, and sensitivity of a 
DFE for identifying ophthalmic disease at an early stage 
when it can be treated most effectively. Patients may not 
understand the implications of their diagnosis of diabetes, 
or may underestimate their personal risk of developing 
diabetic retinopathy. Thus, the less than optimal screening 
rates can be attributed to patient, provider and system chal-
lenges (Zhang et al 2007). This paper describes the costs of 
a patient-centered intervention.
We have previously described a randomized controlled 
trial of a telephone-based intervention to increase adherence 
with DFE screening recommendations in a population of 
predominantly low income minority adults with diabetes in 
Bronx, NY (Walker et al 2008). The telephone intervention 
produced a 74% increase in retinopathy screening compared 
with a standard print intervention (Walker et al 2008). Here 
we outline the costs associated with implementing this 
intervention and estimate its cost-effectiveness.
Methods
The telephone intervention itself has been described elsewhere 
(Walker et al 2008). Brieﬂ  y, adult patients with diabetes 
from 3 primary care settings in Bronx, NY, most of them 
poor and from minority groups, who had not had a DFE 
within the preceding 12 months were randomly assigned to 
the print or telephone intervention. The print group received 
a mailed pamphlet with information about retinal disease 
in diabetes and its prevention through DFE. The colorful, 
low-literacy pamphlet is similar to literature mailed by many 
health maintenance organizations to their enrollees. Those in 
the telephone intervention group received up to 7 telephone 
calls from trained bilingual health educators over the 6-month 
intervention period. During the telephone calls, time was 
devoted to establishing rapport, educating about diabetes 
eye complications, and the rationale for routine DFEs, and 
problem solving regarding the logistics of arranging for their 
DFE. The interventionists would not, however, make the 
appointments for the patients, as the goal of the intervention 
was to activate and empower patients who were in health care 
systems to have this screening exam. Once the patient reported 
having obtained a DFE, no further calls were made.
The perspective of this analysis is that of a provider of 
health care to a population of patients with diabetes. We have 
excluded from the analysis any costs that were associated 
speciﬁ  cally with the research aspects of the trial (as opposed to 
implementation of the intervention). And in estimating costs we 
have applied ﬁ  gures representative of current levels in the US, 
as opposed to the actual costs incurred in our speciﬁ  c setting.
Intervention logs were kept of all attempted and 
completed calls, including the time of initiation and termina-
tion. To assess costs, we tallied the number of calls to each 
patient, their durations, and the number of attempted calls that 
were not completed (such as no answer, busy signal, wrong 
number, not at home). We then associated several types of 
costs with each call.
The minimal qualiﬁ  cations for our interventionists/health 
educators were a bachelor’s degree in a social science or 
health education and excellent communication skills. The 
costs of labor for the health educators during the phone calls 
was accounted at an average salary of US$36,500 per year, 
based on US median earnings for this job category identi-
ﬁ  ed from a commercial compensation database (PayScale, 
Inc. 2008). At the start of the program, each interventionist 
received approximately 20 hours of training about diabe-
tes, retinopathy, counseling for behavior change, and the 
resources available in our setting. We estimated that all calls, 
whether completed or not, required 5 minutes of preparation 
time (eg, to locate and review the records). For completed 
calls, an additional 5 minutes were required afterward for 
making notes and re-ﬁ  ling the chart. The health educators 
received 1 hour of supervision for every 20 hours of inter-
vention work from a nurse certiﬁ  ed diabetes educator. We 
assessed training and supervision time at the hourly rate of 
the health educators plus the salary of the supervisor. We 
attributed an annual salary of US$70,000 to the supervisor, 
a slight increment above the median US$59,140 reported 
for a registered nurse credentialed as a certiﬁ  ed diabetes 
educator (PayScale, Inc. 2008), in recognition of the wage 
premium typically accorded supervisory work. In addition 
to base salary, all labor costs incurred an additional 28% 
charge for fringe beneﬁ  ts. Telephony charges were accounted 
at US$0.05 for each call (completed or attempted), plus an 
additional US$0.10 for each minute’s duration of a com-
pleted call.
Because an intervention of this nature would normally 
be implemented by assigning the telephone intervention 
responsibility to existing personnel whose skills are similar 
to those of health educators, we have not included costs for 
ofﬁ  ce space or recruitment in our analysis. We also assume 
that the magnitude of telephony generated would not require 
capital investment in additional equipment in the typical 
setting. Similarly, although our intervention maintained 
separate records, in a clinical setting, record keeping would 
ordinarily be done in the regular clinical chart, so we have 
not counted any costs for paper, ﬁ  ling cabinets, or other 
related supplies.Clinical Ophthalmology 2008:2(4) 765
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The effectiveness of the telephone intervention, the 
number of DFEs generated by the intervention, was calcu-
lated as the difference in probabilities of DFE in the telephone 
and print groups, multiplied by the number of people in the 
telephone group. A cost-effectiveness ratio was calculated 
as the cost of the intervention divided by the number of 
DFEs gained. Because the time-frame of the intervention 
and its sequelae was only 6 months, no discounting was 
applied to costs or effects.
Probabilistic sensitivity analysis was performed by gener-
ating 1,000 bootstrap samples from the clinical trial data set 
of individual patient records, thus capturing the uncertainty 
in the effectiveness of the intervention and the uncertainty in 
the number and duration of calls (Hunink et al 1998). We also 
calculated the cost-effectiveness ratio for a limited version of 
the intervention that terminates after the ﬁ  fth call.
All calculations were carried out using Stata version 
10 MP (Stata Corp., College Station, TX, USA).
Results
Study sample
Three hundred and ﬁ  ve patients were randomized to the 
telephone intervention, and 298 to the print group. The mean 
age of all participants was 56.6 years, and 61% were women. 
Forty-ﬁ  ve percent self-identiﬁ  ed as black, and 17% as white; 
the remainder were other or did not choose a racial identi-
ﬁ  cation. Twenty-three percent chose to use Spanish during 
the study, and 42.5% self-identiﬁ  ed as Hispanic. Forty-two 
percent were married or living with a partner. The median 
education level was a high school diploma, median household 
income fell in the US$15,000–30,000 range. Overall access 
to health care in this study group was good, as they were 
recruited from the panels of primary care treatment centers: 
90.1% had some form of health insurance. The intervention 
groups did not differ signiﬁ  cantly on any demographic or 
socioeconomic variable.
Median duration of diabetes at randomization was 7 years, 
interquartile range 3–11 years. Fully 10% of participants 
had been diagnosed with diabetes 20 or more years earlier. 
Baseline ophthalmic health information was not available in 
this study. Self-reported prior laser photocoagulation therapy, 
blindness in both eyes, proliferative retinopathy, and other seri-
ous vision problems were exclusion criteria for the study.
Base case
Labor inputs
Providing the telephone intervention to the 305 intervention 
group participants required a total of 4,147 attempted calls, 
plus 930 calls resulting in contact with the patients, having 
a total duration of 8,212 minutes. Health educator pay for 
these calls therefore totaled US$14,890.83 (including fringe 
beneﬁ  ts). In addition, 52 hours of training and supervision 
time, costing US$3,535.63, were required.
Telephony charges
Telephony charges of US$871.80 were incurred for 930 
completed calls totaling 8,212 minutes, and 4,147 unsuc-
cessful call attempts.
Total costs, effectiveness, and cost-effectiveness ratio
The total costs were therefore US$19,298.26. Of the 305 tele-
phone group participants 103 (33.8%) ultimately underwent 
DFE within 6 months of randomization, compared with 57 
(19.5%) of 293 controls. The intervention thus resulted in a 
gain of 43.7 DFEs, which were associated with an additional 
3 incident diagnoses of macular edema and 16.4 incident 
diagnoses of diabetic retinopathy While most of these cases 
were background or mild nonproliferative retinopathy, they 
do include 1 case of severe nonproliferative, and 2 cases 
of proliferative disease. At these visits, 1 macular and 3 
pan-retinal laser photocoagulations were recommended. An 
additional 4 patients were advised to have further evaluation 
by ﬂ  uorescein angiography. No surgical treatments were pre-
scribed. The print intervention cost US$2.04 per participant 
for the brochure, envelope, postage, and mailing labor. Thus 
the incremental cost of the telephone intervention above the 
print intervention was US$18,676.06. Therefore the incre-
mental cost-effectiveness ratio is estimated at US$427.37 
per DFE gained.
Sensitivity analysis
Limited intervention sensitivity analysis
Most of the participants who received a DFE did so fairly 
early during the intervention period. If we view the total time 
spent on telephone calls leading up to the DFE as a “survival” 
time (with DFE as the end event, and subjects with no DFE 
censored at the end of their last call), we can examine the 
impact of additional phone contact using survival analysis. 
Figure 1 shows the Kaplan-Meier survival function estimator, 
and a smoothed hazard function for our study. It is evident 
that the probability of obtaining a DFE if the participant had 
not already done so in the ﬁ  rst 60 minutes of total telephone 
contact time is quite small.
It is probably impractical to limit the intervention to 
60 minutes of telephone contact. But it would be pos-
sible to terminate the intervention after a smaller number Clinical Ophthalmology 2008:2(4) 766
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of calls. Nearly all participants who obtained a DFE did 
so after 4 or fewer calls; all did so by the ﬁ  fth call. No 
additional DFEs took place after the sixth or seventh 
calls. Had we stopped our intervention after 5 calls, we 
would still have gained the same number of DFE events, 
but we would have avoided 1,221 call attempts, and 50 
completed calls lasting a total of 391 minutes. Thus a total 
of US$3265.30 in labor, supervision, and telephony costs 
could have been saved with no loss in effectiveness. The 
cost-effectiveness ratio would have been US$352.65 per 
DFE gained.
Probabilistic sensitivity analysis
Holding the salaries, fringe levels, and telephony charges 
constant at their base case levels, we repeated our analysis 
reﬂ  ecting the uncertainty in the intervention effectiveness 
and the number and duration of calls required, using 1,000 
bootstrap samples from the original clinical trial results.
Table 1 presents statistics describing the various types 
of costs, total costs, and cost-effectiveness ratio in this sen-
sitivity analysis.
Discussion
Our base case estimate of approximately US$427 per DFE 
gained is the product of a limited analysis. A full cost-utility 
analysis would require estimating the number of years 
of improved vision that result from these DFEs. To truly 
estimate this would entail long-term follow-up of the study 
participants, which was outside the scope of this study. It is 
possible, indeed likely, that sustained DFE utilization would 
require periodic “boosters” of the intervention as well. For 
these reasons, we have limited our analysis to estimating the 
cost per additional DFE obtained. The fact that the additional 
DFEs yielded an additional 16.4 new diagnoses of diabetic 
retinopathy suggests that, at least initially, this screening 
process is efﬁ  cient.
The intervention we have studied goes far beyond a mere 
“reminder” call. The health educators spent time with partici-
pants promoting both self-motivation and problem-solving 
assistance. Because such an intervention is labor intensive 
and cannot be carried out by untrained staff, not surprisingly, 
health educator labor accounts for the vast majority of total 
costs of this intervention.
Our intervention is considerably more effective than 
mailed reminders. Within our own study, the telephone 
group’s participation in DFE screening exceeded that of 
the print group by 74%. Similar contrasts have been found 
by others. For example, Halbert et al increased DFE uptake 
by only 1.6 DFEs per 100 persons using multiple mailed 
reminders (Halbert et al 1999). They did not report the costs 
of their approach.
Relatively few cost-effectiveness analyses of interven-
tions aimed at increasing utilization of established preventive 
measures have been published. Fishman et al (2000) com-
pared 3 approaches to enhance mammography utilization in 
a managed care population of women who did not respond 
to a letter advising them to schedule a screening mammo-
gram: a post-card reminder, a simple reminder call, and a 
motivational call. In their study, a simple reminder call cost 
US$92 for each mammogram generated. They found that 
motivational calling was more expensive but no more effec-
tive than simple reminder calling, so they did not calculate 
a cost-effectiveness ratio for that strategy. Their estimate of 
mammograms generated is questionable, however, because 
Table 1 Bootstrap statistics for cost components, total costs, and cost-effectiveness ratio
Cost component (US$)  5th %ile  25th %ile  50th %ile  75th %ile  95th %ile
Health educators  13,483.59  14,243.18  14,758.26  15,286.20  15,994.79
Training and supervision  3,330.33  3,441.14  3,516.29  3,593.31  3,696.69
Telephony charges  789.23  833.52  865.45  895.88  941.00
Net costs (compared with print)  16,990.26  17,895.05  18,517.45  19,160.16  20,005.12
Incremental cost per additional DFE  304.05  367.79  429.41  517.91  692.52
Abbreviation: DFE, dilated fundus examination.
Figure 1 Telephone time until dilated fundus examination.
Kaplan-Meier survival estimate
Smoothed hazard estimate
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lacking a control group, they simply assumed that half of the 
observed mammograms would have occurred in the absence 
of intervention. Our intervention is more complex than theirs 
in that we made multiple calls (3.1 per participant on aver-
age). Fishman’s population, women served by Group Health 
Cooperative of Puget Sound in western Washington state, 
probably enjoys many socioeconomic advantages compared 
with our study population. And the barriers to arranging a 
DFE for our participants were also more formidable than the 
barriers to scheduling a mammogram for Fishman’s managed 
care members, especially considering that Fishman’s callers, 
unlike ours, had access to the appointment scheduling and 
could make the appointment for the patient during the call.
McDowell et al (1986) compared 3 methods of recalling 
patients for inﬂ  uenza vaccination in four Canadian primary 
care practices: personal reminder by physician, a letter, or 
a telephone call from a nurse. They found the telephone 
intervention to be the most effective, increasing vaccina-
tion probability from 9.8% among controls to 37.0%. Their 
single telephone call lasted, on average, 2 min 43 sec. They 
did not count time spent attempting incomplete calls, nor 
do they include any costs for training or supervision. Their 
cost-effectiveness ratio, which assumed nurses were paid 
US$40,000 per year, was approximately US$4 per vac-
cination gained. Obtaining a vaccination can be very quick 
and simple, particularly if it has been pre-ordered by the 
physician: a short visit to the nurse is all that is required. By 
contrast, to have a DFE one must have an appointment with 
an ophthalmologist or optometrist, which typically entails 
a wait, and which may be subject to last-minute reschedul-
ing. Mydriatic drops are administered, and one waits while 
they take effect. While the examination itself may last only 
a few moments, the patient may not be able to resume nor-
mal activities until the effect of the dilating drops wears off 
some time later. Thus the barriers to obtaining a ﬂ  u shot are 
substantially less than those for a DFE
We found no publications examining the cost-effectiveness 
of interventions that were fully comparable to ours in duration 
or intensity, in accounting methods, or in the difﬁ  culties to be 
overcome by the intervention, especially in our low-income 
urban minority population.
We see that our intervention is more expensive per unit 
outcome than other published approaches to increasing the 
use of preventive services, because our intervention is far 
more labor intensive than the others. We could have saved 
slightly more than 17% of the cost of our intervention had 
we terminated it after 5 telephone calls, and not a single DFE 
would have been lost through this modiﬁ  cation. Fewer calls 
might have been needed, and the intervention might have 
been more effective, in a setting where interventionists had 
the ability to schedule appointments for the patients. Other 
approaches to reducing the cost of this intervention are not 
apparent. Some health care providers can obtain telephone 
service for lower charges than we have assumed, but tele-
phony charges are only a small fraction of our total costs.
Labor costs dominate our expenses. The intervention may 
not be effectively delivered by personnel less skilled in health 
education and counseling than we budgeted in our analysis, and 
the amount of training and supervision provided was modest by 
any standard. Conceivably, outsourcing the telephone calls to 
health educators in a lower-wage country might result in sav-
ings, but callers’ foreign accents or other aspects of language 
or cultural differences, and unfamiliarity with our health care 
system, might well reduce the effectiveness of the interven-
tion. The cost-effectiveness ratio may also be improved if a 
health system with an efﬁ  cient appointment system adopted 
our intervention, so that the two activities were linked.
Diabetic retinopathy strikes approximately 50% of people 
with diabetes during their lifetimes, and despite the avail-
ability of effective treatment for early disease, it remains the 
leading cause of blindness among adults. It accounts for 10% 
of the total cost of diabetic complications (Caro et al 2002), 
amounting to just over US$4,700 over 30 years for each 
person with type 2 diabetes. Although the technical aspects 
of diagnosis and treatment are well reﬁ  ned, the logistics of 
identifying early, treatable diabetic retinopathy are daunting. 
Complementary to efforts like ours that enhance participation 
in DFE screening, others have sought alternatives to DFE 
screening, such as retinal photography in the primary care set-
ting, which is not as demanding of patient time and effort.
Clearly the challenge of diabetic retinopathy is no lon-
ger solely a biomedical one: it must also be solved through 
effective delivery of health services, proactive providers, and 
more motivated and empowered consumers. The barriers to 
care faced by poor, urban minority populations are difﬁ  cult 
to surmount, and their vulnerability to diabetic complications 
is great. Yet we have shown that much can be achieved if 
we are willing to pay a moderate cost. If not, society will 
pay the medical, social, and personal costs for preventable 
cases of vision loss and blindness. A just society would 
bear this cost to give its poorest people their best chance at 
preserving eyesight.
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